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High blood pressure is a major risk factor for cardiovascular disease and is influenced by
both environmental and genetic factors. Epigenetic processes including DNA methylation
potentially mediate the relationship between genetic factors, the environment and cardio-
vascular disease. Despite an increased risk of hypertension and cardiovascular disease in
individuals of South Asians compared to Europeans, it is not clear whether associations
between blood pressure and DNA methylation differ between these groups.
Methods
We performed an epigenome-wide association study and differentially methylated region
(DMR) analysis to identify DNA methylation sites and regions that were associated with sys-
tolic blood pressure, diastolic blood pressure and hypertension. We analyzed samples from
364 European and 348 South Asian men (first generation migrants to the UK) from the Sou-
thall And Brent REvisited cohort, measuring DNA methylation from blood using the Illumina
Infinium® HumanMethylation450 BeadChip.
Results
One CpG site was found to be associated with DBP in trans-ancestry analyses (i.e. both eth-
nic groups combined), while in Europeans alone seven CpG sites were associated with
DBP. No associations were identified between DNA methylation and either SBP or hyper-
tension. Comparison of effect sizes between South Asian and European EWAS for DBP,
SBP and hypertension revealed little concordance between analyses. DMR analysis identi-
fied several regions with known relationships with CVD and its risk factors.
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Conclusion
This study identified differentially methylated sites and regions associated with blood pres-
sure and revealed ethnic differences in these associations. These findings may point to
molecular pathways which may explain the elevated cardiovascular disease risk experi-
enced by those of South Asian ancestry when compared to Europeans.
Introduction
Hypertension results from abnormalities in the control systems that normally regulate
blood pressure [1]. It is one of the strongest risk factors for cardiovascular disease (CVD)
which is the leading cause of death worldwide [2, 3]. People of South Asian descent have
increased risk of CVD compared to Europeans [4, 5]. In South Asians living in the United
Kingdom, death rate from stroke is between 20% and 25% greater than the rest of the popu-
lation [6]. Associations between SBP or DBP and stroke are also stronger in South Asians
than Europeans [4].
DNA methylation is an example of an environmentally responsive, mitotically stable,
epigenetic mark that is associated with biological processes, including those leading to high
blood pressure and stroke [7–9]. Furthermore, candidate gene analyses in cell-line and ani-
mal studies have demonstrated a role of DNA methylation in the pathogenesis of hyperten-
sion [10–14]. For one of these genes, HSD11B2, DNA methylation has also been associated
with hypertension in humans [15]. One recent study found associations between systolic
and diastolic BP and DNA methylation among participants of European, Hispanic and Afri-
can American decent [16]. We aimed to identify DNA methylation associated with SBP,
DBP and hypertension in peripheral blood of European and South Asian men in data col-
lected using the Infinium HumanMethylation450 (HM450) BeadChip. We analyzed all
samples together in a trans-ancestry analysis, then conducted analyses in each ethnic group
separately. We hypothesised that BP associated epigenetic marks would differ between South
Asian and European groups, highlighting potential mechanisms explaining the disparity in
CVD and stroke risk between the two ethnicities.
Results
Trans-ancestry EWAS analyses
SBP. In the unadjusted EWAS investigating the association between DNA methylation
and SBP we identified four CpG sites with Bonferroni-corrected p-value< 1.24×10−07 (Table A
in S1 File). After adjustment for potential confounders these associations were markedly atten-
uated (Table B in S1 File).
DBP. In the unadjusted EWAS investigating the association between DNA methylation
and DBP we identified two CpG sites, with Bonferroni-corrected p-value (Table C in S1 File).
After adjustment for potential confounders, the associations identified in the unadjusted
EWAS were markedly attenuated. However, one additional CpG site (cg07598370 near
OR5AP2) was identified in the adjusted EWAS, below the Bonferroni-corrected threshold
(Fig 1 and Table D in S1 File). DBP was associated with lower DNA methylation at this CpG
site with a 0.1% decrease in DNA methylation per 1 mmHg increase in DBP. The mean and
standard deviation (SD) of DNA methylation at this CpG site in the European group was 0.84
(0.07) and in the South Asian group was 0.83 (0.05).
High blood pressure and DNA methylation
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Hypertension. In the unadjusted EWAS investigating the association between DNA
methylation and hypertension, we identified two CpG sites, falling below the Bonferroni-cor-
rected p-value threshold (Table E in S1 File). After adjustment for potential confounders, the
associations identified in the unadjusted EWAS were markedly attenuated and no longer asso-
ciated (Table F in S1 File).
European EWAS
SBP. In the EWAS investigating the association between SBP and DNA methylation, no
CpG sites were associated with SBP after correction for multiple testing (G and H Tables in
S1 File).
DBP. In the unadjusted EWAS investigating the association between DNA methylation
and DBP, we identified three CpG sites with Bonferroni-corrected p-value<1.24×10−07
(Table I in S1 File). In the fully adjusted EWAS, two of the three CpG sites: cg16241714 (in the
gene body of CEBPD), cg00006122 (near the gene C12orf44), were identified as falling below
the Bonferroni-corrected threshold (Table J in S1 File). Their direction of association was
consistent with the unadjusted EWAS. In addition to these two CpG sites, cg04751533 near
Fig 1. Manhattan plot indicating the associations between DBP and DNA methylation of men of European and South Asian ancestry. The plot demonstrates
the associations between DBP and DNA methylation of European and South Asian men collectively. The model was adjusted for confounders, estimated cell
counts and principal components. The uncorrected log10(p-values) are plotted on the y-axis. The blue line is drawn to separate the CpG sites that surpassed p-
value<1×10−05, a threshold for a suggestive association and the red line to separate the CpG sites that surpassed the Bonferroni-corrected threshold (p-
value<1.24×10−07). The CpG sites that surpassed the Bonferroni-corrected threshold were considered to be associated with the trait.
https://doi.org/10.1371/journal.pone.0227728.g001
High blood pressure and DNA methylation
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AFAP1 was found to be associated with DBP a 0.16% decrease in DNA methylation per 1
mmHg increase in DBP observed at this CpG site (Fig 2 and Table J in S1 File).
Hypertension. In theEWAS investigating the association between hypertension and DNA
methylation, no CpG sites were associated with hypertension after correction for multiple test-
ing (K and L Tables in S1 File).
South Asian EWAS
SBP. In the unadjusted EWAS investigating the association between DNA methylation
and SBP, we identified one CpG site (cg07963349 in the gene body of GALR2), which fell
below the Bonferroni-corrected p-value<1.24×10−07 (Table M in S1 File). In the fully adjusted
EWAS, this CpG site was no longer associated after correction for multiple testing but the
direction of association was consistent between models (Table N in S1 File).
DBP. In the EWAS investigating the association between DBP and DNA methylation, no
CpG site was associated following correction for multiple testing (O and P Tables in S1 File).
Hypertension. In both unadjusted and fully adjusted EWAS investigating the association
between hypertension and DNA methylation, no CpG site was associated following correction
for multiple testing (Q and R Tables in S1 File).
Fig 2. A Manhattan plot indicating the associations between DBP and DNA methylation in European men. The plot demonstrates the associations between
DBP and DNA methylation in European men. The model was adjusted for confounders, estimated cell counts and principal components. The uncorrected–log10
(p-values) are plotted on the y-axis. The blue line is drawn to separate the CpG sites that surpassed p-value<1×10−05, the threshold suggestive of an association and
the red line to separate the CpG sites that surpassed the Bonferroni threshold (p-value<1.24×10−07). The CpG sites that surpassed the Bonferroni threshold were
considered to be associated with the trait.
https://doi.org/10.1371/journal.pone.0227728.g002
High blood pressure and DNA methylation
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The genomic inflation factor, lambda, for all fully adjusted models is provided in Table 1.
Comparison of effect sizes between trans-ancestry, European and South
Asian EWAS
The magnitude of associations between European and South Asian populations taken from the
fully adjusted EWAS of SBP, DBP and hypertension were compared to each other using a lin-
ear fit and a random intercept and slope multilevel model in a pair-wise comparison. There
was little consistency between the EWAS of Europeans and South Asians (goodness-of-fit
R2 = 0 for SBP, DBP and hypertension (Fig 3)).
Differentially methylated region analysis
DMR analyses were carried out to identify regions of DNA methylation that were associated
with SBP, DBP and hypertension. As in the EWAS analyses, DMR analysis was conducted for
the full trans-ancestry group, and additionally for European and South Asian sub-groups.
Trans-ancestry DMR analysis identified 395 regions of methylation variation (mapped to 326
annotated genes) for SBP, 237 regions (mapped to 157 annotated genes) for DBP and 0 DMRs
for hypertension using a FDR-corrected p-value<0.05 (S-XTables in S1 File). Twelve DMRs
annotated to genes were common between trans-ancestry SBP and trans-ancestry DBP at FDR
p-value<0.05 (Table 2).
In Europeans, 348 DMRS for SBP (mapped to 291 annotated genes), 95 for DBP (mapped to
74 annotated genes) and 0 for hypertension were identified using a FDR-corrected p-value<0.05.
Fig 3. Consistency between fully adjusted EWAS of SBP, DBP and hypertension between Europeans and South Asian. DNA methylation associations are
shown for 402331 common CpG sites across three EWAS analyses. Each green dot represents a CpG site and the positions of the dots are determined by the effect
size in each analysis. The grey lines on each dot denote the confidence intervals (CI) for the estimates. A linear fit of the overall correspondence summarises
correlation between compared associations (green dashed line). Grey dashed line shows the line of equality in effect sizes between pairs of analyses. R2 = goodness
of linear fit and as such is a measure of the consistency between two EWAS.
https://doi.org/10.1371/journal.pone.0227728.g003
Table 1. Levels of genomic inflation (Lambda) for each EWAS comparison after correcting for confounders
including cell counts.
DBP SBP Hypertension
Trans-ancestry 1.07 0.94 1.12
European 1.08 1.00 0.92
South Asian 1.00 0.94 0.99
https://doi.org/10.1371/journal.pone.0227728.t001
High blood pressure and DNA methylation
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Nine DMRs annotated to genes were common between European SBP and European DBP at
FDR p-value<0.05 (Table 2). In South Asians, 96 DMRs for SBP (mapped to 66 annotated
genes), 186 DBP (mapped to 135 annotated genes) and 0 hypertension DMRs were identified
using a FDR-corrected p-value<0.05. Thirty-five DMRs annotated to genes were common
between South Asian SBP and South Asian DBP at FDR p-value<0.05 (Table 2).
We created Venn diagrams to identify overlap between DMRs (mapped to genes) of SBP
and DBP analyses conducted for South Asian and European groups (Fig 4). For SBP, there
Table 2. Overlap of DMRs between fully adjusted DMR analysis of SBP and DBP for trans-ancestry, Europeans
and South Asians respectively.




































� when a gene is common between trans-ancestry and European analyses,
�� when a gene is common between trans-ancestry and South Asian analyses.
https://doi.org/10.1371/journal.pone.0227728.t002
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were three genes in common (WRN, PTPRN2 and CACNA1A). For DBP, there was one DMR
in common between South Asian and European groups (PRDM16).
We performed pathway analyses for the genes mapped for DMRs of SBP and DBP analyses
conducted for South Asian and European groups. For SBP analyses conducted for Europeans
and DBP analyses conducted for South Asians, we identified pathways enriched with FDR
q-value<0.05. The identified pathways for SBP analyses conducted for Europeans were
NOTCH2 intracellular domain regulates transcription and NOTCH4 intracellular domain reg-
ulates transcription. The identified pathway for DBP analyses conducted for South Asians was
insulin-like growth factor-2 mRNA binding proteins (IGF2BPs/IMPs/VICKZs) bind RNA.
Known genetic variants in DMRs. Two of the twelve DMRs common in trans-ancestry
SBP and DBP analysis, TFAP2D and HLX, contain SNPs previously associated with blood
pressure [17, 18]. The genetic variant in the PDZD2 DMR was previously associated with myo-
cardial infarction [18]. HLX was also identified in DMR analysis of SBP and DBP in Europeans
(Table 2). PRDM16 was found to be common to SBP and DBP in Europeans, its genetic variants
were previously associated with dilated cardiomyopathy [19]. PRKAG2 was found to be common
to SBP and DBP in South Asians, and has been previously associated with hypertrophic cardio-
myopathy [20] and chronic kidney disease [21]. Other identified genes previously reported in
GWAS to be associated with CVD-related traits were ELL2 (GWAS of BP [17], insulin [22] and
glucose [22]), TRPS1 (GWAS of BP [17]), PID1 (GWAS of stroke [23], lung function [24] and
chronic obstructive pulmonary disease [25]) and WIPF1 (GWAS of resting heart rate [26]).
Comparison with previous EWAS
We looked up 126 associations reported earlier [16] that also appeared in the trans-ancestry
EWAS of SBP and DBP in our study (Table Y in S1 File). The evidence of associations for
these sites was generally weaker in our study. The effect sizes were heterogeneous for the
majority of associations but the magnitude of difference between two studies was small.
cg19693031 (near TXNIP) and cg18120259 (in gene body LOC100132354), found within
the top hundred CpG sites of the trans-ancestry EWAS of SBP in our analyses, were among
the 126 previously reported associations [16]. The direction of effect was consistent with
the previous analysis and the magnitude of association was slightly larger in our study. The
Fig 4. Venn diagrams to identify overlap between DMRs (mapped to genes) of DBP (A) and SBP (B) analyses conducted for South Asian and European
groups. SA denotes South Asian and Eu denotes European ancestry.
https://doi.org/10.1371/journal.pone.0227728.g004
High blood pressure and DNA methylation
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above reported cg18120259 was also the top CpG site in our trans-ancestry EWAS of hyperten-
sion, the direction of effect was consistent but the magnitude of association was stronger in
our study. These CpG sites were also replicated previously [16].
Discussion
We investigated the association between SBP, DBP and hypertension and DNA methylation
measured in peripheral blood of European and South Asian men combined and then across
individual ethnicities using the HM450 BeadChip array. In the trans-ancestry fully adjusted
EWAS, we found DBP was associated with methylation at one CpG site (cg07598370 near
OR5AP2) below the Bonferroni-corrected threshold. A genetic variant near the olfactory
receptor, family 5, subfamily AP, member 2 (OR5AP2) has been previously reported to be
associated with hematological phenotypes [27], in addition olfactory receptors are known to
regulate blood pressure via their renal expression [28]. Evidence has shown that renal sensory
receptors play an important role in blood pressure regulation and olfactory receptors belong-
ing to this group of sensory receptors[29]. SBP and hypertension were not associated with
DNA methylation after adjustment for confounders, estimated cell counts and PCs. EWAS
were also conducted in European and South Asian groups separately. In Europeans fully
adjusted EWAS, three CpG sites were associated with DBP with a Bonferroni-corrected p-
value below the threshold imposed. In South Asians fully adjusted EWAS, SBP, DBP and
hypertension were not associated with DNA methylation after multiple testing corrections.
Several of the initial associations observed in the unadjusted model of DBP were noted to be
documented loci responsive to tobacco smoking CpG sites, for example, (cg05575921 [30],
cg12803068 [31], cg03636183 [32], cg22132788 [33] and cg09935388 [34]), hence their attenu-
ation on adjustment for smoking was predictable. This highlights the capacity of DNA methyl-
ation to index exposure to relevant risk factors.
We found three CpG sites associated with DBP in Europeans. One CpG site (cg04751533),
in the gene body of AFAP (actin filament-associated protein), acts as an actin-binding and
crosslinking protein and is enriched in SRC and phorbol ester induced podosomes [35]. Podo-
somes are specialized plasma-membrane actin-based microdomains and have been suggested
to play a role in arterial vessel remodeling [36]. C12orf44 (cg00006122) encodes autophagy-
related protein 101 that is also known as ATG101. ATG101 is an autophagy related protein,
with relevance to blood pressure because autophagy plays a key role in pulmonary vascular
remodelling via regulation of apoptosis and hyperproliferation of pulmonary arterial endothe-
lial cells [37]. ATG101 is an essential gene for the initiation of autophagy and may be involved
in endothelial cell growth through regulation of autophagy in pulmonary hypertension [37].
CEBPD (cg16241714) encodes CCAAT/enhancer binding protein delta. CEBPD is involved in
the regulation of apoptosis and cell proliferation and there is evidence that it might acts as
tumour suppressor [38].
We compared the results of trans-ancestry analyses to previously reported EWAS of BP.
Although the current study is smaller in size, we found evidence of some overlap between our
results and the recent EWAS. Our study is the first blood pressure EWAS to our knowledge
that has included South Asians, offering the chance to compare results from European and
South Asian individuals.
There was no consistency in the magnitude and direction of associations comparing
Europeans to South Asians, suggesting that peripheral blood DNA methylation patterns may
differ between Europeans and South Asians in relation to blood pressure. This may reflect
the fact that DNA methylation could index exposure to a different suite of risk factors in
the two ethnic groups, or that different mechanisms contribute to the pathogenesis of
High blood pressure and DNA methylation
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hypertension and its related phenotypic traits. Of note, the South Asian participants in the
Southall and Brent REvisited (SABRE) study are first generation migrants, arriving in the
UK as young adults. The potential early life and developmental antecedents of hypertension
and blood pressure will therefore be considerably different between the two ethnic groups.
This may explain to some extent the lack of consistency in methylation variable loci observed
between the two ethnic groups. However, the study has limited statistical power due to the
relatively modest sample size for these analyses and would benefit from replication in
another sample of South Asian ancestry.
Where associations were observed, the effect sizes were modest in size between cases and
controls at the identified CpG sites. Such differences are unlikely to have profound biological
consequences but may in turn exert a polygenic-like effect, altering disease risk or trait charac-
teristics by small amounts. Further work is required to understand the functional conse-
quences of such subtle shifts in DNA methylation.
We carried out DMR analysis and identified a large number of DMRs for SBP and DBP
in the trans-ancestry, European and South Asian subgroups. The analyses found support
for some of the DMRs for CVD related traits in the literature including BP [17], myocardial
infarction [18]¸ dilated cardiomyopathy [19] and stroke [23]. There was some overlap between
DMRs (mapped to genes) of SBP and DBP analyses conducted for South Asian and European
groups. For SBP, there were three genes in common (WRN, PTPRN2 and CACNA1A). There
is evidence that WRN (Werner syndrome RecQ like helicase) protein plays an important role
in DNA repair and in DNA replication[39, 40]. A previous study has shown that cells lacking
WRN exhibit deletion of telomeres from single sister chromatids [41]. PTPRN2 (protein tyro-
sine phosphatase, receptor type, N polypeptide 2) encodes a major autoantigen of relevance
to type 1 diabetes [42, 43]. The CACNA1A (calcium voltage-gated channel subunit alpha1 A)
is located on chromosome 19p13 that encodes the main subunit (1A) of the neuronal P/Q type
voltage-gated calcium-ion channel[44]. Mutations in this gene have been associated with
various neurological phenotypes [44]. For DBP, there was one DMR in common between
South Asian and European groups (PRDM16). PRDM16 (histone-lysine N-methyltransferase
PRDM16) functions as a transcriptional regulator[45] and a previous study confirmed a causal
role for this locus in human myocardial disease [19].
The strengths of this study include the study design where participants were from two dif-
ferent ethnicities; European and South Asian that were analysed collectively and individually
using robust statistical methods. Additionally, the utilisation of HM450 arrays provided good
coverage of the genome in terms of known annotated genes (although in total only covers
<2% of all CpGs). The relatively modest sample size, the utilisation of only male participants
and measurement of BP twice are among the limitations of this work.
Conclusion
In conclusion, we identified associations between methylation and DBP across trans-ancestry
and European-specific analyses. Lack of associations identified in South Asian specific analyses
indicates that the associations between methylation and blood pressure may be different
between European and South Asian populations.
Methods
Participant’s information
SABRE is a population-based cohort including 4,857 people of European, South Asian and
African Caribbean origin aged 40 to 69 living in West London, UK [46]. Peripheral blood sam-
ples were collected from the Southall participants at baseline (1988–91) for DNA extraction.
High blood pressure and DNA methylation
PLOS ONE | https://doi.org/10.1371/journal.pone.0227728 January 30, 2020 9 / 16
In the current analysis, 800 (400 European and 400 South Asian) samples from the SABRE
cohort were randomly selected from available baseline samples of good DNA quality. Some
samples were removed from the data set during quality control procedures and some samples
were excluded due to missing information. After exclusion, 712 (364 European and 348 South
Asian) individuals remained. We utilised EPISTRUCTURE[47] to conduct principal compo-
nent analysis on a subset of 4913 genetically informative methylation probes. We were able to
clearly differentiate between self-reported European and South Asian individuals. We did not
identify any evidence of population substructure or admixture within either self-reported
ancestral group.
These 712 individuals did not have known diabetes or coronary heart disease at baseline
and were stratified by four-year age group and ethnicity. The SABRE study predominantly
focused on the recruitment of men[46], for that reason epigenetic analyses were restricted to
male participants.
Ethnicity in the SABRE cohort was assigned based on grand-parental origins from partici-
pant questionnaire. Blood pressure was measured on one occasion (the average of 2 consecu-
tive readings) in the baseline research clinic as described previously [46].
All participants gave written informed consent. Approval for the baseline study was
obtained from Ealing, Hounslow and Spelthorne, Parkside and University College London
research ethnics committees. Characteristics of participants are shown in Table 3.
Traits of interest
We investigated SBP, DBP and hypertension as our traits of interest. Hypertension was defined
as occurrence of SBP�140 mm Hg and/or DBP�90 mm Hg, or receiving medication for
hypertension as described previously [46]. The BP protocol was based on the INTERSALT
study protocol [48].
Covariates
Models were adjusted for age (years), body mass index (BMI) (kg/m2), ethnicity (European or
South Asian for trans-ancestry analyses), smoking status (never or ever smoking) and social
class (manual or non-manual occupation). Age, ethnicity, smoking status and social class of
participants were collected from questionnaires. BMI was calculated from clinic measures of
height and weight.
Table 3. Distributions of study characteristics included in the EWAS analysis of SBP, DBP and hypertension.
Trans-ancestry European South Asian P-value
N 712(100%) 364(51.12%) 348(48.88%)
Hypertension cases 126(100%) 54(42.86%) 72(57.14%) 0.02�
SBP 122.7(10.6) 122.0(10.7) 123.5(10.3) 0.24
DBP 78.4(17.4) 76.8(18.1) 80.0(16.6) 8.3×10−5
Age (years)
Mean (SD)
51(7.1) 52(7.2) 51(7.0) 0.06
BMI (kg/m2)
mean (SD)
25.8(3.5) 26.0(3.3) 25.7(3.6) 0.3
Smokers (ever smokers) 361(100%) 112(31.02%) 266(73.68%) <0.001�
Social class (Manual) 473(100%) 264(55.81%) 231(48.84%) 0.15�
P-value: t-test for differences between European and South Asian groups and
�P-value = Fisher’s exact test.
https://doi.org/10.1371/journal.pone.0227728.t003
High blood pressure and DNA methylation
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DNA methylation and pre-processing
DNA was bisulfite converted using the Zymo EZ DNA Methylation™ kit (Zymo, Irvine, CA).
Following conversion, DNA methylation was measured using the HM450 BeadChip in line
with standard protocols at the University of Bristol, UK [49].
Samples failing QC (average probe detection p value�0.01) were repeated and if unsuccess-
ful excluded from further analysis. BeadChip intensity data were converted to β-values using
the minfi package [50] in the R statistical programming language. Methylation beta values
range from 0 (no cytosine methylation) to 1 (completely cytosine methylated). Raw beta values
were normalised using the Functional Normalisation method of the minfi package [51]. We
excluded control probes (n = 65), any probes with a detection p-value > 0.05 in more than 5%
samples, non-CpG probes, polymorphic probes (defined as SNP-overlapping probes, probes
with a SNP at the target CpG site, or probes with a SNP at the base next to the target CpG)
and probes with a minor-allele frequency (MAF)� 5%; based on UCSC common SNPs track
for dbSNP build 137. We further excluded probes that are considered as cross-hybridizing
[52]. We applied this stringent CpG filtering because polymorphic and cross-hybridizing
probes can interfere with accurate detection of methylation levels. After excluding these fea-
tures, 402,331 probes remained for the analysis.
Estimation of cell counts
Cell count estimates were derived using the reference-based Houseman method [53] in the R
minfi package [50] using the Reinius et al. dataset as reference [54]. This method estimates the
relative proportions of six white blood cell subtypes (CD4+ T-lymphocytes, CD8+ T-lympho-
cytes, NK (natural killer) cells, B-lymphocytes, monocytes and granulocytes).
Statistical analyses
Epigenome-wide association study (EWAS) analysis. We considered a trans-ancestry
analysis as the primary model because this provided maximal statistical power by enabling us
to include all participants. Our primary hypothesis was that the potential epigenetic mecha-
nisms of elevated blood pressure would be different across these two ethnicities. However, we
postulated that these differences may be common to key loci, rather than being at completely
different loci.
Three sets of EWAS analyses were run to identify CpG sites associated with either SBP,
DBP or hypertension. Normalised, untransformed beta-values, which are on a scale of 0
(completely unmethylated) to 1 (completely methylated) were utilised. Multiple linear regres-
sion models were run to evaluate the association between traits of interest and DNA methyla-
tion. Analyses were run for each ethnic subgroup and with all samples combined in a trans-
ancestry analysis. To remove potential batch effects, principal components (PCs) were gener-
ated from methylation beta values using Principal Component Analysis (PCA) [55–57]. The
PCs were generated for trans-ancestry and for individual ethnicities separately. The first four
PCs were included as covariates in each of the EWAS. These PCs were not associated with
exposure (i.e. SBP, DBP and hypertension) and captured 27%,27% and 28% of the variance for
trans-ancestry, Europeans and South Asians respectively.
Two models were run for each trait of interest: i) an unadjusted model and ii) a model
adjusted for confounders (age, BMI, ethnicity (where appropriate), smoking status, social class
(occupational status according to the 1980 Registrar Generals classification of occupation; non
manual or manual)), estimated cell counts (n = 6) and PCs. We adjusted for the confounders
which we a priori selected on the basis that it was plausible they would influence blood pres-
sure and blood DNA methylation[58].
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The genomic inflation factor (lambda) was computed and Manhattan plots were generated
to compare the genome wide distribution of p-values in EWAS. CpG sites with Bonferroni-
corrected p-value<1.24×10−07 were considered to be associated with the trait of interest. We
considered the fully adjusted trans-ancestry models as the primary analysis models.
Differentially methylated region analysis. In addition to EWAS analyses, differentially
methylated region (DMR) analyses in relation to SBP, DBP and hypertension were conducted
separately using the R package DMRcate [59]. In the DMR analysis, normalised, untrans-
formed beta-values were used and the models were adjusted for confounders, estimated cell
counts and PCs. DMRcate groups associated probes into separate DMRs if the gap between
nucleotides is�1000 base pairs. P-values for associations were adjusted for multiple testing
using the BH method and by the DMRcate algorithm.
Pathway analyses were carried out using the reactome (https://reactome.org/) to test the
genes mapped for DMRs for enrichment of certain biological pathways.
Comparison with previous EWAS. A large EWAS study of SBP and DBP was recently
conducted in amongst individuals of European, African American and Hispanic/Latino ances-
try (n = 17,101) [16]. The study conducted an overall meta-analysis of the discovery and repli-
cation cohorts and identified 126 CpG sites associated with BP after Bonferroni correction
(p-value<1.0 × 10−7). We compared our EWAS results of SBP and DBP of trans-ancestry anal-
ysis to this previously published EWAS of SBP and DBP.
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